Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 7, 2007

View Archived Issues

Novel treatment options for cancer outlined in recent patent literature

New agents for psychopharmacologic disorders described in recent patents

Clera patent discloses novel imaging agents for Parkinson's disease

AstraZeneca announces second quarter 2007 results

Novavax initiates clinical trial for VLP-based influenza vaccine

Ovation begins clinical trial of i.v. carbamazepine for epilepsy

Valeant completes enrollment of first retigabine pivotal phase III study

Orphan drug designation of LX-211 recommended by EMEA committee

Mecamylamine augmentation for the treatment of depression

First-in-man study of a compound targeting CENP-E

Ovarian cancer vaccine stimulates immune response in a phase I trial

MacroGenics initiates three clinical trials with teplizumab in type 1 diabetes

Univ. Birmingham selects Eden Biodesign to develop and produce novel autoimmune disease drug

ORG-26576 enhanced AMPA receptor function and increased working memory in animal studies

Genta and Emisphere submit IND for oral G-4544 formulation

Tobira completes Series A financing and licenses rights to Takeda anti-HIV compounds

Nuvelo reduces workforce and readjusts development programs

Rosetta Genomics and Ben Gurion University to collaborate on microRNA-based applications

Advanced Cell Technology and Mytogen enter merger agreement

OncoGenex begins enrollment for OGX-427 phase I trial for cancer

Enzon enrolls patients in PEG-SN38 phase I study for solid tumors or lymphoma

MedImmune begins phase IIa trial of MEDI-528 for asthma

Rheoscience and Dr. Reddy's begin phase III study of balaglitazone

New HIV Tat vaccine induces humoral and cell-mediated immune responses in mice

Interim results show improved lipid profiles in HIV patients treated with boosted Invirase

FDA approves Indevus's Sanctura XR for once-daily treatment of OAB

Health Canada approves GW and Bayer's Sativex for cancer pain

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...